文献速递临床微生物分子诊断

基于MALDI-TOF质谱与机器学习的抗菌药物耐药性预测验证研究

Prediction of antimicrobial resistance from MALDI-TOF mass spectra using machine learning: a validation study.
PubMed 文献 · J Clin Microbiol · 2025-11-26

该研究利用德国常规诊断和瑞士DRIAMS-A数据库的大肠埃希菌、肺炎克雷伯菌和金黄色葡萄球菌质谱数据,验证六种机器学习模型预测抗菌药物耐药性的性能。结果显示在本地数据上预测性能良好(AUROC≥0.8),但模型跨地点跨时间应用性能差,且训练后18个月内性能下降,需本地训练并定期再训练。

要点

  • 基于MALDI-TOF质谱的机器学习模型预测AMR在本地数据上AUROC≥0.8。
  • 模型跨地点跨时间应用性能差,需本地数据训练并定期再训练。
  • 训练后18个月内性能下降,金黄色葡萄球菌苯唑西林耐药AUROC降0.10。

核心结论

  • 基于MALDI-TOF数据的机器学习预测AMR性能良好(AUROC≥0.8),但分类器需本地数据训练并定期再训练以维持性能。

研究设计与样本

  • 验证研究,使用德国常规诊断和瑞士DRIAMS-A数据库的大肠埃希菌(n=7,897)、肺炎克雷伯菌(n=2,444)和金黄色葡萄球菌(n=4,664)质谱数据。
  • 采用交叉验证对六种分类模型(正则化逻辑回归、多层感知机、支持向量机、随机森林、梯度提升机LGBM和XGB)进行AMR预测基准测试。
  • 训练后前瞻性观察18个月模型性能。

主要发现

  • DRIAMS-A数据集与本数据的AMR预测平均AUROC相当。
  • 本数据最佳预测性能:金黄色葡萄球菌苯唑西林耐药(随机森林,AUROC 0.85)、大肠埃希菌环丙沙星耐药(XGB,AUROC 0.83)、肺炎克雷伯菌哌拉西林-他唑巴坦耐药(XGB,AUROC 0.81)。
  • 若训练与测试数据在地点和时间上不相关,机器学习性能差。
  • 训练后18个月内性能下降:金黄色葡萄球菌苯唑西林耐药(随机森林,AUROC变化-0.10)、大肠埃希菌环丙沙星耐药(XGB,-0.19)、肺炎克雷伯菌哌拉西林-他唑巴坦耐药(XGB,-0.25)。

关键数值与推荐

  • 本数据上金黄色葡萄球菌苯唑西林耐药随机森林模型AUROC为0.85。
  • 本数据上大肠埃希菌环丙沙星耐药XGB模型AUROC为0.83。
  • 本数据上肺炎克雷伯菌哌拉西林-他唑巴坦耐药XGB模型AUROC为0.81。
  • 训练后18个月内AUROC变化:金黄色葡萄球菌苯唑西林耐药随机森林-0.10,大肠埃希菌环丙沙星耐药XGB -0.19,肺炎克雷伯菌哌拉西林-他唑巴坦耐药XGB -0.25。

临床怎么用

  • MALDI-TOF质谱结合机器学习可较常规药敏试验提前一天提供AMR预测结果,有助于严重感染的早期目标治疗。
  • 机器学习模型需基于本地数据训练并定期再训练以维持预测性能。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Matrix-assisted laser desorption-ionization-time of flight (MALDI-TOF) mass spectra can be used to predict antimicrobial resistance (AMR) using machine learning (ML). This study aimed to validate the performance of ML models for AMR prediction using own and publicly available MALDI-TOF data and to test how these models perform over time. Mass spectra of Escherichia coli (n = 7,897), Klebsiella pneumoniae (n = 2,444), and Staphylococcus aureus (n = 4,664) from routine diagnostics (Germany) and the DRIAMS-A database (Switzerland) were used. Six classification models were benchmarked for AMR prediction using cross-validation (regularized logistic regressions [LR], multilayer perceptrons [MLP], support vector machines [SVM], random forests [RF], gradient boosting machines [LGBM, XGB]). Performance was prospectively observed for 18 months after training. The performance of AMR prediction evaluated by the mean area under the receiver operating characteristic curve (AUROC) was comparable between the DRIAMS-A data set and own data. The best predictive performance (classifier, AUROC) on own data was achieved for oxacillin resistance in S. aureus (RF, 0.85), ciprofloxacin resistance in E. coli (XGB, 0.83), and piperacillin-tazobactam resistance in K. pneumoniae (XGB, 0.81). ML performance was poor if training and test data were unrelated in terms of location and time. Performance (change in AUROC) decreased within 18 months after training for S. aureus (oxacillin resistance, RF: -0.10), E. coli (ciprofloxacin, XGB: -0.19), and K. pneumoniae (piperacillin-tazobactam, XGB: -0.25). The performance of ML for the prediction of AMR based on MALDI-TOF data is good (AUROC ≥ 0.8) but classifiers need to be trained on local data and retrained regularly to maintain the performance level. IMPORTANCE: MALDI-TOF mass spectrometry can be used not only for bacterial species identification but also for the prediction of antimicrobial resistance (AMR) using machine learning (ML). Such an approach would provide antimicrobial susceptibility test results one day earlier than conventional routine diagnostics. This is essential for an early targeted treatment to reduce mortality of severe infections. We show that the performance of ML for the prediction of AMR based on MALDI-TOF data is good (AUROC ≥ 0.8). However, the ML models need to be trained on local data and retrained regularly to maintain a good performance.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Wiesmann N, Enders D, Westendorf A, et al. Prediction of antimicrobial resistance from MALDI-TOF mass spectra using machine learning: a validation study. J Clin Microbiol. 2025. PMID: 41296602. doi:10.1128/jcm.01186-25

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。